APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Valsartan Tablets Industry Growth and Trends Forecast to 2032

2 January 2026109 pages

Choose your research edition.

Industry ResearchValsartan Tablets Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Tablets Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Valsartan Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Tablets Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Valsartan Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Valsartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Valsartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valsartan Tablets include Alembic, Aurobindo, Cadista, Camber, Lupin, Major, Repackagers, Solco Healthcare and Changzhou Siyao Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Valsartan Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Valsartan Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Valsartan Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Valsartan Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Valsartan Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Valsartan Tablets Market by Company

Alembic

Aurobindo

Cadista

Camber

Lupin

Major

Repackagers

Solco Healthcare

Changzhou Siyao Pharmaceutical

Mylan

Teva

Zhejiang Huahai Pharm

Valsartan Tablets Segment by Type

80mg

40mg

320mg

160mg

Valsartan Tablets Segment by Application

Clinic

Hospital

Recovery Center

Valsartan Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valsartan Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Valsartan Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 80mg Table 2. Major Company of 40mg Table 3. Major Company of 320mg Table 4. Major Company of 160mg Table 5. Global Valsartan Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Valsartan Tablets Sales by Type (2021-2026) & (K Units) Table 7. Global Valsartan Tablets Sales Market Share in Volume by Type (2021-2026) Table 8. Global Valsartan Tablets Sales by Type (2021-2026) & (US$ Million) Table 9. Global Valsartan Tablets Sales Market Share in Value by Type (2021-2026) Table 10. Global Valsartan Tablets Price by Type (2021-2026) & (US$/Unit) Table 11. Global Valsartan Tablets Sales by Type (2027-2032) & (K Units) Table 12. Global Valsartan Tablets Sales Market Share in Volume by Type (2027-2032) Table 13. Global Valsartan Tablets Sales by Type (2027-2032) & (US$ Million) Table 14. Global Valsartan Tablets Sales Market Share in Value by Type (2027-2032) Table 15. Global Valsartan Tablets Price by Type (2027-2032) & (US$/Unit) Table 16. North America Valsartan Tablets Sales by Type (2021-2026) & (K Units) Table 17. North America Valsartan Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Valsartan Tablets Sales by Type (2021-2026) & (K Units) Table 19. Europe Valsartan Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Valsartan Tablets Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Valsartan Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Valsartan Tablets Sales by Type (2021-2026) & (K Units) Table 23. Latin America Valsartan Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Valsartan Tablets Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Valsartan Tablets Sales by Type (2021-2026) & (US$ Million) Table 26. Valsartan Tablets Industry Trends Table 27. Valsartan Tablets Industry Drivers Table 28. Valsartan Tablets Industry Opportunities and Challenges Table 29. Valsartan Tablets Industry Restraints Table 30. Global Valsartan Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Valsartan Tablets Revenue Market Share by Company (2021-2026) Table 32. Global Valsartan Tablets Sales by Company (2021-2026) & (K Units) Table 33. Global Valsartan Tablets Sales Share by Company (2021-2026) Table 34. Global Valsartan Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Valsartan Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Valsartan Tablets Major Company Production Sites and Headquarters Table 37. Global Valsartan Tablets Company, Product Type & Application Table 38. Global Valsartan Tablets Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Valsartan Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Valsartan Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Valsartan Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Valsartan Tablets Sales Market Share in Volume by Region (2021-2026) Table 44. Global Valsartan Tablets Sales by Region (2021-2026) & (US$ Million) Table 45. Global Valsartan Tablets Sales Market Share in Value by Region (2021-2026) Table 46. Global Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Valsartan Tablets Sales by Region (2027-2032) & (K Units) Table 48. Global Valsartan Tablets Sales Market Share in Volume by Region (2027-2032) Table 49. Global Valsartan Tablets Sales by Region (2027-2032) & (US$ Million) Table 50. Global Valsartan Tablets Sales Market Share in Value by Region (2027-2032) Table 51. Global Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Valsartan Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Valsartan Tablets Sales by Application (2021-2026) & (K Units) Table 54. Global Valsartan Tablets Sales Market Share in Volume by Application (2021-2026) Table 55. Global Valsartan Tablets Sales by Application (2021-2026) & (US$ Million) Table 56. Global Valsartan Tablets Sales Market Share in Value by Application (2021-2026) Table 57. Global Valsartan Tablets Price by Application (2021-2026) & (US$/Unit) Table 58. Global Valsartan Tablets Sales by Application (2027-2032) & (K Units) Table 59. Global Valsartan Tablets Sales Market Share in Volume by Application (2027-2032) Table 60. Global Valsartan Tablets Sales by Application (2027-2032) & (US$ Million) Table 61. Global Valsartan Tablets Sales Market Share in Value by Application (2027-2032) Table 62. Global Valsartan Tablets Price by Application (2027-2032) & (US$/Unit) Table 63. North America Valsartan Tablets Sales by Application (2021-2026) & (K Units) Table 64. North America Valsartan Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Valsartan Tablets Sales by Application (2021-2026) & (K Units) Table 66. Europe Valsartan Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Valsartan Tablets Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Valsartan Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Valsartan Tablets Sales by Application (2021-2026) & (K Units) Table 70. Latin America Valsartan Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Valsartan Tablets Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Valsartan Tablets Sales by Application (2021-2026) & (US$ Million) Table 73. Alembic Company Information Table 74. Alembic Business Overview Table 75. Alembic Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Alembic Valsartan Tablets Product Portfolio Table 77. Alembic Recent Development Table 78. Aurobindo Company Information Table 79. Aurobindo Business Overview Table 80. Aurobindo Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Aurobindo Valsartan Tablets Product Portfolio Table 82. Aurobindo Recent Development Table 83. Cadista Company Information Table 84. Cadista Business Overview Table 85. Cadista Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Cadista Valsartan Tablets Product Portfolio Table 87. Cadista Recent Development Table 88. Camber Company Information Table 89. Camber Business Overview Table 90. Camber Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Camber Valsartan Tablets Product Portfolio Table 92. Camber Recent Development Table 93. Lupin Company Information Table 94. Lupin Business Overview Table 95. Lupin Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Lupin Valsartan Tablets Product Portfolio Table 97. Lupin Recent Development Table 98. Major Company Information Table 99. Major Business Overview Table 100. Major Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Major Valsartan Tablets Product Portfolio Table 102. Major Recent Development Table 103. Repackagers Company Information Table 104. Repackagers Business Overview Table 105. Repackagers Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Repackagers Valsartan Tablets Product Portfolio Table 107. Repackagers Recent Development Table 108. Solco Healthcare Company Information Table 109. Solco Healthcare Business Overview Table 110. Solco Healthcare Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Solco Healthcare Valsartan Tablets Product Portfolio Table 112. Solco Healthcare Recent Development Table 113. Changzhou Siyao Pharmaceutical Company Information Table 114. Changzhou Siyao Pharmaceutical Business Overview Table 115. Changzhou Siyao Pharmaceutical Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Changzhou Siyao Pharmaceutical Valsartan Tablets Product Portfolio Table 117. Changzhou Siyao Pharmaceutical Recent Development Table 118. Mylan Company Information Table 119. Mylan Business Overview Table 120. Mylan Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Mylan Valsartan Tablets Product Portfolio Table 122. Mylan Recent Development Table 123. Teva Company Information Table 124. Teva Business Overview Table 125. Teva Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Teva Valsartan Tablets Product Portfolio Table 127. Teva Recent Development Table 128. Zhejiang Huahai Pharm Company Information Table 129. Zhejiang Huahai Pharm Business Overview Table 130. Zhejiang Huahai Pharm Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Zhejiang Huahai Pharm Valsartan Tablets Product Portfolio Table 132. Zhejiang Huahai Pharm Recent Development Table 133. North America Valsartan Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. North America Valsartan Tablets Sales by Country (2021-2026) & (K Units) Table 135. North America Valsartan Tablets Sales Market Share by Country (2021-2026) Table 136. North America Valsartan Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 137. North America Valsartan Tablets Sales Market Share Forecast by Country (2027-2032) Table 138. North America Valsartan Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Valsartan Tablets Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Valsartan Tablets Market Share by Country (2021-2026) Table 141. North America Valsartan Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Valsartan Tablets Market Share Forecast by Country (2027-2032) Table 143. Europe Valsartan Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Europe Valsartan Tablets Sales by Country (2021-2026) & (K Units) Table 145. Europe Valsartan Tablets Sales Market Share by Country (2021-2026) Table 146. Europe Valsartan Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 147. Europe Valsartan Tablets Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Valsartan Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Valsartan Tablets Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Valsartan Tablets Market Share by Country (2021-2026) Table 151. Europe Valsartan Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Valsartan Tablets Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Valsartan Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Valsartan Tablets Sales by Country (2021-2026) & (K Units) Table 155. Asia-Pacific Valsartan Tablets Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Valsartan Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 157. Asia-Pacific Valsartan Tablets Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Valsartan Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Valsartan Tablets Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Valsartan Tablets Market Share by Country (2021-2026) Table 161. Asia-Pacific Valsartan Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Valsartan Tablets Market Share Forecast by Country (2027-2032) Table 163. Latin America Valsartan Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Latin America Valsartan Tablets Sales by Country (2021-2026) & (K Units) Table 165. Latin America Valsartan Tablets Sales Market Share by Country (2021-2026) Table 166. Latin America Valsartan Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 167. Latin America Valsartan Tablets Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Valsartan Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Valsartan Tablets Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Valsartan Tablets Market Share by Country (2021-2026) Table 171. Latin America Valsartan Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Valsartan Tablets Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Valsartan Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Valsartan Tablets Sales by Country (2021-2026) & (K Units) Table 175. Middle East and Africa Valsartan Tablets Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Valsartan Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 177. Middle East and Africa Valsartan Tablets Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Valsartan Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Valsartan Tablets Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Valsartan Tablets Market Share by Country (2021-2026) Table 181. Middle East and Africa Valsartan Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Valsartan Tablets Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Valsartan Tablets Distributors List Table 186. Valsartan Tablets Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Valsartan Tablets Image Figure 2. Global Valsartan Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Valsartan Tablets Sales (2021-2032) & (K Units) Figure 5. 80mg Image Figure 6. Global 80mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 40mg Image Figure 8. Global 40mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 320mg Image Figure 10. Global 320mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. 160mg Image Figure 12. Global 160mg Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Valsartan Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Valsartan Tablets Market Share by Type 2025 VS 2032 Figure 15. North America Valsartan Tablets Sales Market Share in Volume by Type in 2025 Figure 16. North America Valsartan Tablets Sales Market Share in Value by Type in 2025 Figure 17. Europe Valsartan Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Europe Valsartan Tablets Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Valsartan Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Valsartan Tablets Sales Market Share in Value by Type in 2025 Figure 21. Latin America Valsartan Tablets Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Valsartan Tablets Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Valsartan Tablets Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Valsartan Tablets Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Valsartan Tablets Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Recovery Center Image Figure 32. Global Recovery Center Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Valsartan Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Valsartan Tablets Market Share by Application 2025 VS 2032 Figure 35. North America Valsartan Tablets Sales Market Share in Volume by Application in 2025 Figure 36. North America Valsartan Tablets Sales Market Share in Value by Application in 2025 Figure 37. Europe Valsartan Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Europe Valsartan Tablets Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Valsartan Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Valsartan Tablets Sales Market Share in Value by Application in 2025 Figure 41. Latin America Valsartan Tablets Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Valsartan Tablets Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Valsartan Tablets Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Valsartan Tablets Sales Market Share in Value by Application in 2025 Figure 45. North America Valsartan Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Valsartan Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Valsartan Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Valsartan Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Valsartan Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Valsartan Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Valsartan Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Valsartan Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Valsartan Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Valsartan Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Valsartan Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Valsartan Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Valsartan Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Valsartan Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Valsartan Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Valsartan Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Valsartan Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Valsartan Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Valsartan Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Valsartan Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Valsartan Tablets Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Valsartan Tablets Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 80mg
  • 40mg
  • 320mg
  • 160mg
Applications
  • Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Alembic
  • Aurobindo
  • Cadista
  • Camber
  • Lupin
  • Major
  • Repackagers
  • Solco Healthcare
  • Changzhou Siyao Pharmaceutical
  • Mylan
  • Teva
  • Zhejiang Huahai Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valsartan Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Valsartan Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Valsartan Tablets Market by Type
  6. 1.3.1 80mg
  7. 1.3.2 40mg
  8. 1.3.3 320mg
  9. 1.3.4 160mg
  10. 1.4 Global Valsartan Tablets Market Size by Type
  11. 1.4.1 Global Valsartan Tablets Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Valsartan Tablets Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Valsartan Tablets Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Valsartan Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Valsartan Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Valsartan Tablets Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Valsartan Tablets Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Valsartan Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Valsartan Tablets Industry Trends
  2. 2.2 Valsartan Tablets Industry Drivers
  3. 2.3 Valsartan Tablets Industry Opportunities and Challenges
  4. 2.4 Valsartan Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Valsartan Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Valsartan Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Valsartan Tablets Price (2021-2026)
  4. 3.4 Global Valsartan Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valsartan Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Valsartan Tablets Company, Product Type & Application
  7. 3.7 Global Valsartan Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valsartan Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valsartan Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valsartan Tablets Tier 1, Tier 2, and Tier 3
4 Valsartan Tablets Regional Status and Outlook
  1. 4.1 Global Valsartan Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Valsartan Tablets Historic Market Size by Region
  3. 4.2.1 Global Valsartan Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Valsartan Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Valsartan Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Valsartan Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Valsartan Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Valsartan Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Valsartan Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Valsartan Tablets by Application
  1. 5.1 Valsartan Tablets Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Valsartan Tablets Market Size by Application
  6. 5.2.1 Global Valsartan Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Valsartan Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Valsartan Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Valsartan Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Valsartan Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Valsartan Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Valsartan Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Valsartan Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alembic
  2. 6.1.1 Alembic Company Information
  3. 6.1.2 Alembic Business Overview
  4. 6.1.3 Alembic Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alembic Valsartan Tablets Product Portfolio
  6. 6.1.5 Alembic Recent Developments
  7. 6.2 Aurobindo
  8. 6.2.1 Aurobindo Company Information
  9. 6.2.2 Aurobindo Business Overview
  10. 6.2.3 Aurobindo Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aurobindo Valsartan Tablets Product Portfolio
  12. 6.2.5 Aurobindo Recent Developments
  13. 6.3 Cadista
  14. 6.3.1 Cadista Company Information
  15. 6.3.2 Cadista Business Overview
  16. 6.3.3 Cadista Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cadista Valsartan Tablets Product Portfolio
  18. 6.3.5 Cadista Recent Developments
  19. 6.4 Camber
  20. 6.4.1 Camber Company Information
  21. 6.4.2 Camber Business Overview
  22. 6.4.3 Camber Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Camber Valsartan Tablets Product Portfolio
  24. 6.4.5 Camber Recent Developments
  25. 6.5 Lupin
  26. 6.5.1 Lupin Company Information
  27. 6.5.2 Lupin Business Overview
  28. 6.5.3 Lupin Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lupin Valsartan Tablets Product Portfolio
  30. 6.5.5 Lupin Recent Developments
  31. 6.6 Major
  32. 6.6.1 Major Company Information
  33. 6.6.2 Major Business Overview
  34. 6.6.3 Major Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Major Valsartan Tablets Product Portfolio
  36. 6.6.5 Major Recent Developments
  37. 6.7 Repackagers
  38. 6.7.1 Repackagers Company Information
  39. 6.7.2 Repackagers Business Overview
  40. 6.7.3 Repackagers Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Repackagers Valsartan Tablets Product Portfolio
  42. 6.7.5 Repackagers Recent Developments
  43. 6.8 Solco Healthcare
  44. 6.8.1 Solco Healthcare Company Information
  45. 6.8.2 Solco Healthcare Business Overview
  46. 6.8.3 Solco Healthcare Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Solco Healthcare Valsartan Tablets Product Portfolio
  48. 6.8.5 Solco Healthcare Recent Developments
  49. 6.9 Changzhou Siyao Pharmaceutical
  50. 6.9.1 Changzhou Siyao Pharmaceutical Company Information
  51. 6.9.2 Changzhou Siyao Pharmaceutical Business Overview
  52. 6.9.3 Changzhou Siyao Pharmaceutical Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Changzhou Siyao Pharmaceutical Valsartan Tablets Product Portfolio
  54. 6.9.5 Changzhou Siyao Pharmaceutical Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mylan Valsartan Tablets Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 Teva
  62. 6.11.1 Teva Company Information
  63. 6.11.2 Teva Business Overview
  64. 6.11.3 Teva Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Teva Valsartan Tablets Product Portfolio
  66. 6.11.5 Teva Recent Developments
  67. 6.12 Zhejiang Huahai Pharm
  68. 6.12.1 Zhejiang Huahai Pharm Company Information
  69. 6.12.2 Zhejiang Huahai Pharm Business Overview
  70. 6.12.3 Zhejiang Huahai Pharm Valsartan Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Zhejiang Huahai Pharm Valsartan Tablets Product Portfolio
  72. 6.12.5 Zhejiang Huahai Pharm Recent Developments
7 North America by Country
  1. 7.1 North America Valsartan Tablets Sales by Country
  2. 7.1.1 North America Valsartan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Valsartan Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Valsartan Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Valsartan Tablets Market Size by Country
  6. 7.2.1 North America Valsartan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Valsartan Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Valsartan Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Valsartan Tablets Sales by Country
  2. 8.1.1 Europe Valsartan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Valsartan Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Valsartan Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Valsartan Tablets Market Size by Country
  6. 8.2.1 Europe Valsartan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Valsartan Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Valsartan Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Valsartan Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Valsartan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Valsartan Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Valsartan Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Valsartan Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Valsartan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Valsartan Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Valsartan Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Valsartan Tablets Sales by Country
  2. 10.1.1 South America Valsartan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Valsartan Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Valsartan Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Valsartan Tablets Market Size by Country
  6. 10.2.1 South America Valsartan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Valsartan Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Valsartan Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Valsartan Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Valsartan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Valsartan Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Valsartan Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Valsartan Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Valsartan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Valsartan Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Valsartan Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Valsartan Tablets Value Chain Analysis
  2. 12.1.1 Valsartan Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Valsartan Tablets Production Mode & Process
  7. 12.2 Valsartan Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Valsartan Tablets Distributors
  10. 12.2.3 Valsartan Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst